
MD, French Board certified in Medical Oncology, French Board certified in Clinical Hematology
Consultant medical oncologist specialising in gastrointestinal, breast, and lung cancers with precision medicine approach
Experience
11 years
Languages
Arabic, English
Location
Dubai Healthcare City, Dubai
Sees
adults
Dr. Ali Chamseddine is a Consultant in Medical Oncology at Dr. Sulaiman Al Habib Medical Group in Dubai Healthcare City. He holds French Board certification in both Medical Oncology and Clinical Hematology and brings over 11 years of clinical expertise. He completed a postdoctoral fellowship at MD Anderson Cancer Center in Texas and previously worked as Senior Consultant at Gustave Roussy Cancer Center in France, one of Europe's leading cancer hospitals.
Dr. Chamseddine treats a broad range of cancers including gastrointestinal cancers (oesophageal, gastric, colorectal, pancreatic, liver, and bile duct), breast cancer, lung cancer, gynaecologic cancers (cervical, ovarian, uterine), prostate and kidney cancers, brain cancers, soft-tissue sarcomas, and lymphomas. He specialises in precision oncology—tailoring treatment based on individual patient biology and genetic markers—as well as immuno-oncology and palliative care. He is actively involved in clinical trials and holds advanced diplomas in hematopoietic stem cell transplantation, personalized medicine, pharmacogenomics, and immuno-oncology from universities in Paris.
Dr. Chamseddine is fluent in English and Arabic and is a good fit for patients seeking specialist cancer care with a focus on personalised, evidence-based treatment strategies and supportive care alongside active cancer treatment.
Special interests: precision medicine and personalised cancer treatment, pharmacogenomics and predictive biomarkers, immuno-oncology, hematopoietic stem cell transplantation, clinical trials, patient-centric treatment approaches.
Extracted from the doctor's hospital profile — patient-friendly terms
MD
Not specified
University Diploma in Allogeneic Hematopoietic Stem Cell Transplantation
University of Paris VI School of Medicine, Pierre-et-Marie-Curie, France · 2014
ECGMG Certification USMLE (Step 1, Step 2 CS)
Educational Commission for Foreign Medical Graduates, United States · 2015
University Diploma in Personalized Medicine and Pharmacogenomics
University of Paris VI School of Medicine, Pierre-et-Marie-Curie, France · 2017
Master of Science in Clinical Research
University of Paris VI School of Medicine, Pierre-et-Marie-Curie, France · 2017
University Diploma in Immuno-Oncology
University of Paris XI School of Medicine, France · 2019
Postdoctoral Fellowship in Medical Oncology
MD Anderson Cancer Center, University of Texas, United States
Consultant in Medical Oncology
Dr. Sulaiman Al Habib Medical Group, United Arab Emirates
Senior Consultant
Gustave Roussy Cancer Center, France
Postdoctoral Fellow
MD Anderson Cancer Center, University of Texas, United States
Consultations are available in Arabic, English.
Dr. Sulaiman Al Habib Medical Group — Dubai Healthcare City, Dubai Healthcare City, Dubai.
This doctor primarily sees adults.
Commonly treated: Bile Duct Cancer, Bladder Cancer, Brain Cancer, Breast Cancer, Cervical Cancer, Colorectal Cancer, Esophageal Cancer, Gastric Cancer.
Profile compiled from Dr. Sulaiman Al Habib Medical Group's public website (see original profile via the booking link). Data is informational, not medical advice.
Dr. Sulaiman Al Habib Hospital - مستشفى د. سليمان الحبيب
Umm Hurair 2 - Dubai Healthcare City - Dubai
+971 4 429 7777Dr. Sulaiman Al Habib Hospital - مستشفى د. سليمان الحبيب
Dubai Healthcare City, Dubai
Open in Google Maps ↗exact hospital location
Dr. Sulaiman Al Habib Hospital - مستشفى د. سليمان الحبيب: 4.5★ · 4,186 Google reviews — Google rating for the clinic, not this doctor.
No patient reviews yet — be the first.
Visited Dr. Chamseddine? Your experience helps others choose with confidence.
Write the first reviewReviews are written by signed-in users who attest to a visit, screened before publication, and labeled “Patient-reported” until visit verification launches. They are opinions, not medical advice.